featured
Effects of the Port Delivery System With Ranibizumab in Neovascular AMD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Archway Randomized Phase 3 Trial of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration
Ophthalmology 2021 Sep 28;[EPub Ahead of Print], NM Holekamp, PA Campochiaro, M Chang, D Miller, D Pieramici, AP Adamis, C Brittain, E Evans, D Kaufman, KF Maass, S Patel, S Ranade, N Singh, G Barteselli, C RegilloFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.